{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06213831",
            "orgStudyIdInfo": {
                "id": "INCB18424-110"
            },
            "organization": {
                "fullName": "Incyte Corporation",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream",
            "officialTitle": "A Maximal Use Trial of Ruxolitinib Cream in Adult Participants With Prurigo Nodularis",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-to-evaluate-the-safety-and-tolerability-of-maximal-use-ruxolitinib-cream"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-02-27",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-09",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-01-10",
            "studyFirstSubmitQcDate": "2024-01-10",
            "studyFirstPostDateStruct": {
                "date": "2024-01-19",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Incyte Corporation",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "This study is being conducted to determine the safety and tolerability of ruxolitinib 1.5% cream under maximal use conditions in participants with Prurigo Nodularis (PN)."
        },
        "conditionsModule": {
            "conditions": [
                "Prurigo Nodularis"
            ],
            "keywords": [
                "Prurigo Nodularis",
                "PN",
                "ruxolitinib"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 24,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Maximal Use Ruxolitinib 1.5%",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will apply ruxolitinib 1.5% cream BID through Week 4 to all pruriginous lesions. At Week 4, participants who have completed 4 weeks of treatment with no safety concerns may enter the optional 4-week treatment extension period, during which all participants will apply ruxolitinib 1.5% cream BID to existing pruriginous lesions.",
                    "interventionNames": [
                        "Drug: Ruxolitinib Cream 1.5%"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Ruxolitinib Cream 1.5%",
                    "description": "Ruxolitinib Cream 1.5%",
                    "armGroupLabels": [
                        "Maximal Use Ruxolitinib 1.5%"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of participants with Treatment-emergent Adverse Events (TEAEs)",
                    "description": "Defined as adverse events reported for the first time or worsening of a pre-existing event after first dose of study drug.",
                    "timeFrame": "Up to 16 weeks, including 30 days of safety follow-up"
                },
                {
                    "measure": "Number of participants with TEAEs leading to dose interruption or discontinuation",
                    "description": "Number of participants with TEAEs leading to dose interruption or discontinuation.",
                    "timeFrame": "Up to 16 weeks, including 30 days of safety follow-up"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Ruxolitinib pharmacokinetic (PK) parameters in plasma",
                    "description": "Ruxolitinib concentration in plasma.",
                    "timeFrame": "Up to 16 weeks, including 30 days of safety follow-up"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Clinical diagnosis of PN \u2265 3 months before screening.\n* Pruriginous lesions (defined as papules, nodules, plaques, umbilicated lesions, and linear lesions) on \u2265 2 different body areas (such as right and left leg) at screening and baseline.\n* Total estimated treatment BSA \u2265 25% (excluding the scalp) at screening and baseline.\n* IGA-CPG-S score of \u2265 2 at screening and baseline.\n* Baseline PN-related WI-NRS score \u2265 7. Baseline WI-NRS score is defined as the 7-day average of WI-NRS scores before Day 1 (data from a minimum of 4 out of 7 days prior to Day 1 is needed).\n\nExclusion Criteria:\n\n* Chronic or acute pruritus due to a condition other than PN.\n* Active AD lesions (signs and symptoms other than dry skin) within 6 months of screening and baseline.\n* Acute or chronic active HBV or HCV infection.\n* Any underlying condition known to be associated with the clinical presentation of PN that is not under control (stable) prior to the baseline visit.\n* Any serious illness or medical, physical, or psychiatric condition(s) that, in the investigator's opinion, would interfere with full participation in the study, including administration of study cream and attending required study visits; pose a significant risk to the participant; or interfere with interpretation of study data.\n\nOther protocol-defined Inclusion/Exclusion Criteria may apply.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Incyte Corporation Call Center (US)",
                    "role": "CONTACT",
                    "phone": "1.855.463.3463",
                    "email": "medinfo@incyte.com"
                },
                {
                    "name": "Incyte Corporation Call Center (ex-US)",
                    "role": "CONTACT",
                    "phone": "+800 00027423",
                    "email": "eumedinfo@incyte.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Incyte Medical Monitor",
                    "affiliation": "Incyte Corporation",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Affiliated Dermatology",
                    "status": "RECRUITING",
                    "city": "Scottsdale",
                    "state": "Arizona",
                    "zip": "85255",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.50921,
                        "lon": -111.89903
                    }
                },
                {
                    "facility": "First Oc Dermatology",
                    "status": "RECRUITING",
                    "city": "Fountain Valley",
                    "state": "California",
                    "zip": "92708",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.70918,
                        "lon": -117.95367
                    }
                },
                {
                    "facility": "Amicis Research Center Valencia",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Northridge",
                    "state": "California",
                    "zip": "91324",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.22834,
                        "lon": -118.53675
                    }
                },
                {
                    "facility": "Clinical Science Institute Clinical Research Specialists Inc",
                    "status": "RECRUITING",
                    "city": "Santa Monica",
                    "state": "California",
                    "zip": "90404",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.01945,
                        "lon": -118.49119
                    }
                },
                {
                    "facility": "Olympian Clinical Research",
                    "status": "RECRUITING",
                    "city": "Clearwater",
                    "state": "Florida",
                    "zip": "33756",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.96585,
                        "lon": -82.8001
                    }
                },
                {
                    "facility": "Advanced Pharma Cr, Llc",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33147",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Sullivan Dermatology North Miami Beach Office",
                    "status": "RECRUITING",
                    "city": "North Miami Beach",
                    "state": "Florida",
                    "zip": "33162",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.93315,
                        "lon": -80.16255
                    }
                },
                {
                    "facility": "Lane Dermatology and Dermatologic Surgery",
                    "status": "WITHDRAWN",
                    "city": "Columbus",
                    "state": "Georgia",
                    "zip": "31904",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.46098,
                        "lon": -84.98771
                    }
                },
                {
                    "facility": "Dawes Fretzin Clinical Research Group Llc",
                    "status": "RECRUITING",
                    "city": "Indianapolis",
                    "state": "Indiana",
                    "zip": "46250",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.76838,
                        "lon": -86.15804
                    }
                },
                {
                    "facility": "Oakland Hills Dermatology Pc",
                    "status": "RECRUITING",
                    "city": "Auburn Hills",
                    "state": "Michigan",
                    "zip": "48326",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.68753,
                        "lon": -83.2341
                    }
                },
                {
                    "facility": "Revival Research Institute, Llc Troy",
                    "status": "RECRUITING",
                    "city": "Troy",
                    "state": "Michigan",
                    "zip": "48084",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.60559,
                        "lon": -83.14993
                    }
                },
                {
                    "facility": "Icahn School of Medicine At Mount Sinai",
                    "status": "NOT_YET_RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10029",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Central Sooner Research",
                    "status": "RECRUITING",
                    "city": "Oklahoma City",
                    "state": "Oklahoma",
                    "zip": "73118",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.46756,
                        "lon": -97.51643
                    }
                },
                {
                    "facility": "Paddington Testing Co Inc",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19103",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "International Clinical Research Tennessee Llc",
                    "status": "RECRUITING",
                    "city": "Murfreesboro",
                    "state": "Tennessee",
                    "zip": "37130",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.84562,
                        "lon": -86.39027
                    }
                },
                {
                    "facility": "Dermresearch, Inc.",
                    "status": "RECRUITING",
                    "city": "Austin",
                    "state": "Texas",
                    "zip": "78759",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 30.26715,
                        "lon": -97.74306
                    }
                },
                {
                    "facility": "North Texas Center For Clinical Research Ntccr",
                    "status": "RECRUITING",
                    "city": "Frisco",
                    "state": "Texas",
                    "zip": "75034",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.15067,
                        "lon": -96.82361
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011536",
                    "term": "Prurigo"
                },
                {
                    "id": "D000009450",
                    "term": "Neurodermatitis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000003872",
                    "term": "Dermatitis"
                },
                {
                    "id": "D000017443",
                    "term": "Skin Diseases, Eczematous"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14395",
                    "name": "Prurigo",
                    "asFound": "Prurigo",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12394",
                    "name": "Neurodermatitis",
                    "asFound": "Prurigo Nodularis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7067",
                    "name": "Dermatitis",
                    "relevance": "LOW"
                },
                {
                    "id": "M19712",
                    "name": "Skin Diseases, Eczematous",
                    "relevance": "LOW"
                },
                {
                    "id": "T4769",
                    "name": "Prurigo Nodularis",
                    "asFound": "Prurigo Nodularis",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}